Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells

Journal of Bone and Mineral Research

Volumn 17, Issue 7, 2002, Pages 1190-1199

  Sowa, Hideaki ^a   Kaji, Hiroshi ^a   Yamaguchi, Toru ^a   Sugimoto, Toshitsugu ^a   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ALP; Mineralization; Osteoblast; Smad3; Transforming growth factor

Indexed keywords

ALKALINE PHOSPHATASE; AZETIDINE 2 CARBOXYLIC ACID; COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; PROCOLLAGEN; PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; CALCIUM BINDING PROTEIN; DNA BINDING PROTEIN; HYBRID PROTEIN; MADH3 PROTEIN, RAT; MATRIX GLA PROTEIN; SCLEROPROTEIN; SIALOGLYCOPROTEIN; SMAD3 PROTEIN, HUMAN; SMAD3 PROTEIN, MOUSE; SPP1 PROTEIN, HUMAN; SPP1 PROTEIN, MOUSE; SPP1 PROTEIN, RAT; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; BONE MATRIX; BONE METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; MINERALIZATION; NONHUMAN; NORTHERN BLOTTING; OSSIFICATION; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION; ANIMAL; BONE MINERALIZATION; CELL DIVISION; CELL LINE; CELL SIZE; CYTOLOGY; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; RAT;

ALKALINE PHOSPHATASE; ANIMALS; CALCIFICATION, PHYSIOLOGIC; CALCIUM-BINDING PROTEINS; CELL DIVISION; CELL LINE; CELL SIZE; COLLAGEN TYPE I; DNA-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MICE; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; RATS; RECOMBINANT FUSION PROTEINS; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035991249     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.7.1190     Document Type: Article

References (43)

1. Heterogeneity of latent transforming growth factor-β isolated from bone matrix proteins
2. Transforming growth factor-β gene family members and bone
3. Bone homeostasis
4. TGF-β1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-β1
5. Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur
6. In vivo stimulation of bone formation by transforming growth factor-β
7. Systemic administration of recombinant transforming growth factor β2 (rTGF-β2) stimulates parameters of cancellous bone formation in juvenile and adult rats
8. Transforming growth factor-β reduces the phenotypic expression of osteoblastic MC3T3-E1 cells in monolayer culture
9. Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, OCN, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts
10. Type β transforming growth factor (TGF β) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells
11. Controlling TGF-β signaling
12. Transcriptional control by the TGF-β/Smad signaling system
13. Smad2 overexpression enhances Smad4 gene expression and suppresses CBFA1 gene expression in osteoblastic osteosarcoma ROS17/2.8 cells and primary rat calvaria cells
14. 3
15. 5 integrin subunit expression via Sp1 and Smad signaling
16. 1α,25-dihydroxyvitamin D3 synergism toward transforming growth factor-β1-induced AP-1 transcriptional activity in mouse osteoblastic cells via its nuclear receptor
17. Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators
18. Roles of pathway-specific and inhibitory Smads in activin receptor signaling
19. Multiple extracellular signals promote osteoblast survival and apoptosis
20. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction
21. A simple, rapid, and sensitive DNA assay procedure
22. The quantitative histochemistry of brain. 2. Enzyme measurements
23. Antibodies
24. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts
25. Relationship between actions of transforming growth factor (TGF)-β and cell surface expression of its receptors in clonal osteoblastic cells
26. Diminished incorporation of tritiated thymidine into DNA of MC3T3-E1 cells is related to inhibition of thymidine transport cause by extracellular matrix
27. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria
28. Effects of transforming growth factors β1 and β2 on a mouse clonal, osteoblast-like cell line MC3T3-E1
29. Type-β transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells
30. 1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells
31. Beta-glycerophosphate-induced mineralization of osteoid does not alter expression of extracellular matrix components in fetal rat calvarial cell cultures
32. Mineralization of bone-like extracellular matrix in the absence of functional osteoblasts
33. Expression and regulation of Na-dependent P(i) transport in matrix vesicles produced by osteoblast-like cells
34. Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice
35. Factors influencing synthesis and mineralization of bone matrix from fetal bovine bone cells grown in vitro
36. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype
37. Increased bone formation in OCN-deficient mice
38. Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription
39. Jun inhibits transforming growth factor β-mediated transcription by repressing Smad3 transcriptional activity
40. Induction of the AP-1 members c-Jun and JunB by TGF-β/Smad suppresses early Smad-driven gene activation
41. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type β signaling
42. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis
43. TGF-β-induced repression of CBFA1 by Smad3 decreases cbfa1 and OCN expression and inhibits osteoblast differentiation